Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Solesence (SLSN) EBT (2016 - 2025)

Historic EBT for Solesence (SLSN) over the last 16 years, with Q3 2025 value amounting to -$1.1 million.

  • Solesence's EBT fell 13678.16% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 3690.12%. This contributed to the annual value of $4.5 million for FY2024, which is 20177.92% up from last year.
  • Solesence's EBT amounted to -$1.1 million in Q3 2025, which was down 13678.16% from $3.1 million recorded in Q2 2025.
  • In the past 5 years, Solesence's EBT ranged from a high of $3.1 million in Q2 2025 and a low of -$2.1 million during Q4 2023
  • Moreover, its 5-year median value for EBT was $50000.0 (2022), whereas its average is $95421.1.
  • In the last 5 years, Solesence's EBT soared by 88443.11% in 2021 and then tumbled by 196935.48% in 2023.
  • Over the past 5 years, Solesence's EBT (Quarter) stood at -$357000.0 in 2021, then plummeted by 460.78% to -$2.0 million in 2022, then decreased by 5.99% to -$2.1 million in 2023, then surged by 84.4% to -$331000.0 in 2024, then plummeted by 238.37% to -$1.1 million in 2025.
  • Its last three reported values are -$1.1 million in Q3 2025, $3.1 million for Q2 2025, and $80000.0 during Q1 2025.